Search research articles
Contact Us
Filters
Showing results (61-70 of 286) with videos related to
Page
of 29
Sort By:
Practical Radiation Oncology
|
May 25, 2023
Practical Steps to Mitigate Cybersecurity Attacks on Radiation Oncology Practices
James B Yu, Adam P Dicker, Nataniel H Lester-Coll, et al.
Expert Review of Anticancer Therapy
|
October 16, 2013
Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
Nicholas G Zaorsky, Laura A Doyle, Mark D Hurwitz, et al.
Journal of Neuro-Oncology
|
April 26, 2011
Cediranib enhances control of wild type EGFR and EGFRvIII-expressing gliomas through potentiating temozolomide, but not through radiosensitization: implications for the clinic
Phyllis R Wachsberger, Richard Yaacov Lawrence, Yi Liu, et al.
Journal of the American College of Radiology : JACR
|
December 19, 2012
Predictors of radiation oncology resident research productivity
Jordan M Gutovich, Robert B Den, Maria Werner-Wasik, et al.
Expert Review of Medical Devices
|
December 26, 2014
Is robotic arm stereotactic body radiation therapy “virtual high dose ratebrachytherapy” for prostate cancer? An analysis of comparative effectiveness using published data [corrected]
Nicholas George Zaorsky, Mark D Hurwitz, Adam P Dicker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model
Borbala Daroczi, Gabor Kari, Mary Frances McAleer, et al.
Frontiers in Oncology
|
February 6, 2013
Epidermal growth factor receptor mutation status and rad51 determine the response of glioblastoma to multimodality therapy with cetuximab, temozolomide, and radiation
Phyllis Rachelle Wachsberger, Richard Yaacov Lawrence, Yi Liu, et al.
Expert Review of Medical Devices
|
November 8, 2013
Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer
Nicholas G Zaorsky, Robert B Den, Laura A Doyle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2005
Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma
Phyllis R Wachsberger, Randy Burd, Nichol Marero, et al.
Journal of Oncology Practice
|
November 28, 2012
Pilot study of meaningful use of electronic health records in radiation oncology
Xinglei Shen, Adam P Dicker, Laura Doyle, et al.
Page
of 29
Search research articles
Search
Showing results (61-70 of 286) with videos related to
Sort By:
Page
of 29
Practical Radiation Oncology
|
May 25, 2023
Practical Steps to Mitigate Cybersecurity Attacks on Radiation Oncology Practices
James B Yu, Adam P Dicker, Nataniel H Lester-Coll, et al.
Expert Review of Anticancer Therapy
|
October 16, 2013
Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
Nicholas G Zaorsky, Laura A Doyle, Mark D Hurwitz, et al.
Journal of Neuro-Oncology
|
April 26, 2011
Cediranib enhances control of wild type EGFR and EGFRvIII-expressing gliomas through potentiating temozolomide, but not through radiosensitization: implications for the clinic
Phyllis R Wachsberger, Richard Yaacov Lawrence, Yi Liu, et al.
Journal of the American College of Radiology : JACR
|
December 19, 2012
Predictors of radiation oncology resident research productivity
Jordan M Gutovich, Robert B Den, Maria Werner-Wasik, et al.
Expert Review of Medical Devices
|
December 26, 2014
Is robotic arm stereotactic body radiation therapy “virtual high dose ratebrachytherapy” for prostate cancer? An analysis of comparative effectiveness using published data [corrected]
Nicholas George Zaorsky, Mark D Hurwitz, Adam P Dicker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model
Borbala Daroczi, Gabor Kari, Mary Frances McAleer, et al.
Frontiers in Oncology
|
February 6, 2013
Epidermal growth factor receptor mutation status and rad51 determine the response of glioblastoma to multimodality therapy with cetuximab, temozolomide, and radiation
Phyllis Rachelle Wachsberger, Richard Yaacov Lawrence, Yi Liu, et al.
Expert Review of Medical Devices
|
November 8, 2013
Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer
Nicholas G Zaorsky, Robert B Den, Laura A Doyle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2005
Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma
Phyllis R Wachsberger, Randy Burd, Nichol Marero, et al.
Journal of Oncology Practice
|
November 28, 2012
Pilot study of meaningful use of electronic health records in radiation oncology
Xinglei Shen, Adam P Dicker, Laura Doyle, et al.
Page
of 29